Phibro Animal Health Corporation (PAHC) Stock Forecast & Price Target
Phibro Animal Health Corporation · NASDAQ
$36.35+1.11 (+3.15%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Phibro Animal Health Corporation, 1 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $27.00 to $50.00, a moderate spread. The average target of $40.33 sits 11% above the current $36.35. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.79 next quarter toward $3.34 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy133%
Hold133%
Sell133%
Strong Sell00%
Based on 3 analysts giving stock ratings to Phibro Animal Health Corporation.
As of Jul, 1 of 3 firms rate PAHC a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
PAHC EPS & revenue forecast
EPS · NEXT QUARTER
$0.79
Range $0.79 – $0.79 · 1 analysts · +8% YoY
Next period, 1 analysts expect Phibro Animal Health Corporation to earn $0.79 a share (range $0.79 – $0.79), versus $0.73 a year earlier. , growing to $3.34 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0)., rising to $1.5B next year.
Top analysts covering Phibro Animal Health Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PAHC.
#1
Balaji Prasad
Barclays · Rank #147
Sell
$22.00-39.5% to target
Overall win rate
44%
+ Follow
#2
EK
Ekaterina Knyazkova
JP Morgan
Buy
$50.00+37.6% to target
Coverage
—
+ Follow
#3
Erin Wright
Morgan Stanley
Hold
$26.00-28.5% to target
Coverage
—
+ Follow
#4
Daniel Grosslight
Citigroup
Hold
$44.00+21.0% to target
Coverage
—
+ Follow
#5
Derik De Bruin
B of A Securities
Sell
$27.00-25.7% to target
Coverage
—
+ Follow
PAHC stock forecast FAQ
What is PAHC's average 12-month price target?+
The 3 analysts with a live target average $40.33 for Phibro Animal Health Corporation over the next 12 months, ranging from a $50.00 high to a $27.00 low.
Is PAHC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for PAHC?+
The Street-high target is $50.00 (JP Morgan), and the Street-low is $27.00 (B of A Securities). The average of all 3 active targets is $40.33.
How many Wall Street analysts cover PAHC?+
3 analysts have an active rating on Phibro Animal Health Corporation, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering PAHC?+
Among analysts who currently cover PAHC, Balaji Prasad of Barclays has the strongest overall Quantellect track record (Rank #147). Their current call is Sell with a $22.00 target.
What is Phibro Animal Health Corporation's projected EPS for next quarter?+
The consensus estimate is $0.79 per share (range $0.79 – $0.79) across 1 analysts, rising to $3.34 the following year.
How much revenue is Phibro Animal Health Corporation expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0), growing to $1.5B next year.
Have analysts been upgrading or downgrading PAHC lately?+
As of Jul, 1 of 3 firms rate PAHC a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PAHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
